Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

United Arab Emirates — Emirates Drug Establishment

Tracked across 3 events · 18 articles · First seen Dec 20, 2025 · Last active Aug 17, 2026

Sentiment
63
Attention
4
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 70
Tech
Impact: The United Arab Emirates — Emirates Drug Establishment announced the approval of Onasemnogene abeparvovec, demonstrating its commitment to providing patients with advanced genetic therapies and positioning the United Arab Emirates as a regional hub for pharmaceutical innovation.
Dec 20, 2025 · 6 articles
4 70
Regulatory
Impact: The United Arab Emirates — Emirates Drug Establishment approved Semaglutide (semaglutide) for long-term weight management, reaffirming its commitment to promoting the pharmaceutical ecosystem and addressing obesity challenges.
Jun 01, 2026 · 6 articles
2 50
Regulatory
The United Arab Emirates — Emirates Drug Establishment (EDE) of the United Arab Emirates has approved the expanded use of RINVOQ (upadacitinib), an oral JAK inhibitor developed by AbbVie, for the treatment of non-segmental vitiligo…
Impact: The United Arab Emirates — Emirates Drug Establishment granted the approval, positioning itself as a forward-thinking regulator and facilitating patient access to a novel oral treatment.
Aug 17, 2026 · 6 articles
ERGEN INTELLIGENCE
Track United Arab Emirates — Emirates Drug Establishment live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.